Fig. 3.
VPC with resistance model (upper panel) and with TGI base model (lower panel) after treatment with erlotinib at different dose levels
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.